Terms: = Liver cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Treatment
30 results:
1. [The association between baseline TPOAb and/or TgAb positivity and thyroid immune-related adverse events in patients with malignancies following treatment with immune checkpoint inhibitors].
Gao Y; Ye T; Wu LG; Xu Y; Wang X; Cheng XQ; Zhang YL; Wang YY; Fan XR; Zhao HT; Liu H; Chai XF; Zhang L; Wang MZ; Li NS; Lian XL
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):963-969. PubMed ID: 38514346
[No Abstract] [Full Text] [Related]
2. Menin-mll1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis.
Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J
Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398
[TBL] [Abstract] [Full Text] [Related]
4. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
5. A human fetal liver-derived infant mll-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B.
Mao QG; Liang HQ; Yin YL; Tang JM; Yang JE; Wu CC; Chen Y; Zhang MY; Liu YY; Zheng XT; Zhuang LY; Chen SD
Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101758. PubMed ID: 34303003
[TBL] [Abstract] [Full Text] [Related]
7. TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.
Noura M; Matsuo H; Koyama A; Adachi S; Masutani H
FEBS Open Bio; 2020 Aug; 10(8):1532-1541. PubMed ID: 32511893
[TBL] [Abstract] [Full Text] [Related]
8. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract] [Full Text] [Related]
9. Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis.
Cao L; Wu G; Zhu J; Tan Z; Shi D; Wu X; Tang M; Li Z; Hu Y; Zhang S; Yu R; Mo S; Wu J; Song E; Li M; Song L; Li J
Nat Commun; 2019 Aug; 10(1):3761. PubMed ID: 31434880
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic cancer Patients Receiving Neoadjuvant treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
11. A preliminary study of the local biomechanical environment of liver tumors in vivo.
Ma S; Zhu M; Xia X; Guo L; Genin GM; Sacks MS; Gao M; Mutic S; Hu Y; Hu CH; Feng Y
Med Phys; 2019 Apr; 46(4):1728-1739. PubMed ID: 30730058
[TBL] [Abstract] [Full Text] [Related]
12. [
Guo T; Dong X; Shi G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):551-555. PubMed ID: 30378308
[TBL] [Abstract] [Full Text] [Related]
13. Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid Tumors.
Abrams T; Connor A; Fanton C; Cohen SB; Huber T; Miller K; Hong EE; Niu X; Kline J; Ison-Dugenny M; Harris S; Walker D; Krauser K; Galimi F; Wang Z; Ghoddusi M; Mansfield K; Lee-Hoeflich ST; Holash J; Pryer N; Kluwe W; Ettenberg SA; Sellers WR; Lees E; Kwon P; Abraham JA; Schleyer SC
Clin Cancer Res; 2018 Sep; 24(17):4297-4308. PubMed ID: 29764854
[No Abstract] [Full Text] [Related]
14. Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells.
Liao B; Zhang Y; Sun Q; Jiang P
Cancer Med; 2018 Jan; 7(1):196-207. PubMed ID: 29239146
[TBL] [Abstract] [Full Text] [Related]
15. Pharmacologic Inhibition of the Menin-mll Interaction Leads to Transcriptional Repression of
Kempinska K; Malik B; Borkin D; Klossowski S; Shukla S; Miao H; Wang J; Cierpicki T; Grembecka J
Mol Cancer Ther; 2018 Jan; 17(1):26-38. PubMed ID: 29142068
[TBL] [Abstract] [Full Text] [Related]
16. liver diseases in Adult Life after Childhood cancer in Scandinavia (ALiCCS): A population-based cohort study of 32,839 one-year survivors.
Bonnesen TG; Winther JF; Andersen KK; Asdahl PH; de Fine Licht S; Gudmundsdottir T; Sällfors Holmqvist A; Madanat-Harjuoja LM; Tryggvadottir L; Wesenberg F; Heilmann C; Olsen JH; Hasle H;
Int J Cancer; 2018 Feb; 142(4):702-708. PubMed ID: 29023764
[TBL] [Abstract] [Full Text] [Related]
17. Cooperation of mll/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract] [Full Text] [Related]
18. Adiponectin induces apoptosis in hepatocellular carcinoma through differential modulation of thioredoxin proteins.
Xing SQ; Zhang CG; Yuan JF; Yang HM; Zhao SD; Zhang H
Biochem Pharmacol; 2015 Jan; 93(2):221-31. PubMed ID: 25514170
[TBL] [Abstract] [Full Text] [Related]
19. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.
Gonzalez-Perez A; Jene-Sanz A; Lopez-Bigas N
Genome Biol; 2013; 14(9):r106. PubMed ID: 24063517
[TBL] [Abstract] [Full Text] [Related]
20. Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Cleary SP; Jeck WR; Zhao X; Chen K; Selitsky SR; Savich GL; Tan TX; Wu MC; Getz G; Lawrence MS; Parker JS; Li J; Powers S; Kim H; Fischer S; Guindi M; Ghanekar A; Chiang DY
Hepatology; 2013 Nov; 58(5):1693-702. PubMed ID: 23728943
[TBL] [Abstract] [Full Text] [Related]
[Next]
